Sort
261,768 grants matching “gene therapy”
Bacterial Mechanisms and Host Pharmacokinetic Factors that Determine Persistence
$1,028,211David Alland · Boston Medical Center · U19 · FY2016 · AI
PET, APOE & The Preclinical Course of Alzheimer Disease
$1,028,025Eric M Reiman · Banner Good Samaritan Medical Center · R01 · FY2006 · MH
Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study
$1,027,939Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
INTEGRATED DEVELOPMENT OF NOVEL MOLECULAR MAKERS
$1,027,887Johns Hopkins University · U01 · FY2002 · CA
The Inveon PET/CT for Pre-Clinical Oncology Research
$1,027,842Pat B Zanzonico · Sloan-Kettering Inst Can Research · S10 · FY2012 · OD
THE GENETICS OF VULNERABILITY TO NICOTINE ADDICTIONS
$1,027,800Pamela Ann Madden · Washington University · R01 · FY2008 · DA
Integrated, Individualized, Intelligent Prescribing (I3P)
$1,027,757Joshua C. Denny · Vanderbilt University Medical Center · U01 · FY2016 · HG
Role of Microglia somatic variants in Neurodegenerative diseases
$1,027,639Frederic Geissmann · Sloan-Kettering Inst Can Research · R01 · FY2020 · NS
Integrating targeted therapy and immunotherapy to break through cancer
$1,027,633Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2023 · CA
Integrating targeted therapy and immunotherapy to break through cancer
$1,027,633Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2025 · CA
Platform technology to identify and develop first-in-class anti-fibrotic therapeutics through inhibition of collagen CP4H
$1,027,583Ronald Lennox · Adiutrix Therapeutics · R42 · FY2025 · HL
Clinical Pharmacogenetics
$1,027,532William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
How do genome alterations cause human lung cancer?
$1,027,500Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2017 · CA
How do genome alterations cause human lung cancer?
$1,027,500Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2018 · CA
How do genome alterations cause human lung cancer?
$1,027,500Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2020 · CA
How do genome alterations cause human lung cancer?
$1,027,500Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2016 · CA
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
$1,027,469Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
$1,027,367William C Hahn · Dana-Farber Cancer Inst · U01 · FY2017 · CA
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,027,273Aaron D. Gitler · Stanford University · R35 · FY2018 · NS
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,027,273Aaron D. Gitler · Stanford University · R35 · FY2022 · NS
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,027,273Aaron D. Gitler · Stanford University · R35 · FY2019 · NS
Effects of Standardized Aerobic Exercise-Training on Neurocognitive and Neurodege
$1,027,189Thomas O Obisesan · Howard University · R01 · FY2009 · AG
Studies of neurocysticercosis and animal cestode infections
$1,027,145Theodore Nash · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
iPS-technology and patient specific disease models
$1,027,093Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Diseas
$1,027,075Jorge A. Bezerra · Cincinnati Childrens Hosp Med Ctr · P30 · FY2013 · DK